What is the abbreviation for polio vaccine?
Updated February 2018
| Vaccine | Abbreviation* | Trade Name |
|---|---|---|
| Diphtheria, tetanus and pertussis vaccines (P=Pediatric, A=Adult) | ||
| Polio vaccines | ||
| Inactivated poliovirus vaccine | IPV | Ipol |
| Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | DTaP-IPV | Kinrix Quadracel |
What is DTP Hib?
Diphtheria and tetanus toxoids and pertussis (dif-THEER-ee-a and TET-n-us and per-TUSS-iss) vaccine (also known as DTP vaccine) combined with Haemophilus b conjugate (hem-OFF-fil-us BEE KON-ja-gat) vaccine (also known as Hib vaccine) is a combination immunizing agent used to prevent illness caused by diphtheria.
What is Ippd vaccine?
IPPD is an annual immuniza. tion is actually a test for antibodies. to tubervulosis (TB). We inject a. small amount of purified protein.
What is the abbreviation for vaccination?
*Abbreviations used on U.S. immunization records.
| AVA | Anthrax Vaccine Adsorbed |
|---|---|
| MMR | Measles, Mumps & Rubella Vaccine |
| MMRV | Measles, Mumps, Rubella & Varicella Vaccine |
| MPSV4 | Meningococcal Polysaccharide Vaccine (Quadravalent) |
| MR | Measles-rubella Vaccine |
What is IPV b1?
The 6-in-1 vaccine, also commonly known as the DTaP/IPV/Hib/HepB vaccine, helps protect your child against: diphtheria. tetanus. pertussis (whooping cough) polio.
What is Tetraxim?
TETRAXIM is a vaccine. Vaccines are used to protect against infectious diseases. When TETRAXIM is injected, the body’s natural defences develop a protection against those diseases. TETRAXIM is indicated to help protect the child against diphtheria, tetanus, pertussis and poliomyelitis.
What does MMR stand for?
Measles, Mumps, Rubella (MMR) Vaccine. Vaccine Safety Monitoring.
What is DTP AP vaccine?
DTaP vaccine can prevent diphtheria, tetanus, and pertussis. Diphtheria and pertussis spread from person to person. Tetanus enters the body through cuts or wounds.
What is Prevnar shot for?
(NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine in adults ages 18 years and older.